Sign up to save your podcasts
Or
Share 100% Bullish: Simvastatin in MS, Communicating Risk
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
100% Bullish: Simvastatin in MS, Communicating Risk
Send a text
Originally Aired September 10, 2014: Simvastatin in Secondary Progressive Multiple Sclerosis and Communicating With Patients About Risk Rebecca and Amol want you to: 1. Recognize that simvastatin reduces the rate of whole brain atrophy in secondary progressive MS, which may be a promising new use for statins. 2. Understand that effective strategies to communicate risk include: Using ...
The post 100% Bullish: Simvastatin in MS, Communicating Risk appeared first on Healthy Debate.
View all episodes
By Dr. John Fralick and Dr. Michael Fralick
5
1212 ratings
Send a text
Originally Aired September 10, 2014: Simvastatin in Secondary Progressive Multiple Sclerosis and Communicating With Patients About Risk Rebecca and Amol want you to: 1. Recognize that simvastatin reduces the rate of whole brain atrophy in secondary progressive MS, which may be a promising new use for statins. 2. Understand that effective strategies to communicate risk include: Using ...
The post 100% Bullish: Simvastatin in MS, Communicating Risk appeared first on Healthy Debate.
More shows like The Rounds Table
View all
This American Life
91,243 Listeners
Radiolab
43,827 Listeners
NEJM This Week
320 Listeners
Emergency Medicine Cases
541 Listeners
AFP: American Family Physician Podcast
704 Listeners
JAMA Clinical Reviews
501 Listeners
The Curbsiders Internal Medicine Podcast
3,378 Listeners
Core IM | Internal Medicine Podcast
1,142 Listeners
The Intern At Work: Internal Medicine
67 Listeners
The Clinical Problem Solvers
521 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Critical Care Scenarios
257 Listeners
The Cribsiders
322 Listeners
The Weekly Show with Jon Stewart
10,984 Listeners
What Now? with Trevor Noah
4,322 Listeners